People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...

Novo Nordisk asked US regulators to approve the drug for children ages 6 to 11. In the EU, it's available for adolescents as ...

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP ...

Ozempic and Wegovy are branded versions of semaglutide made by pharmaceutical company Novo Nordisk. Ozempic has been ...

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in ...

As a health journalist, I’m doing my best to keep up with all things weight loss drugs, but with headlines rolling in every ...

The latest addition, Lemme GLP-1 Daily, is marketed as an herbal alternative to GLP-1 agonists — prescription drugs like ...

Novo Nordisk CEO Lars Jørgensen will testify about the high cost of Ozempic and Wegovy at an upcoming HELP Committee hearing on September 24th.

Will Medicare Part D cover Ozempic? Read on to learn more about when Medicare may provide coverage for Ozempic or other ...

Discover what the supplement Lemme GLP-1 Daily does and whether its ingredients are really effective for weight and blood ...

Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same ho ...